Free Trial

CytoMed Therapeutics (GDTC) SEC Filings & 10K Form

CytoMed Therapeutics logo
$2.33 +0.03 (+1.30%)
As of 05/2/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent CytoMed Therapeutics SEC Filings

DateFilerForm TypeView
04/28/2025
3:50 PM
CytoMed Therapeutics (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/28/2025
4:00 PM
CytoMed Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/24/2025
11:01 AM
CytoMed Therapeutics (Subject)
mDR Ltd (Filed by)
Form SCHEDULE 13G/A
03/24/2025
11:03 AM
CytoMed Therapeutics (Subject)
mDR Ltd (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2025
6:09 PM
Choo Chee Kong (Filed by)
CytoMed Therapeutics (Subject)
Form SCHEDULE 13D/A
03/04/2025
2:33 PM
28 Consultants Ltd (Filed by)
CytoMed Therapeutics (Subject)
Form SCHEDULE 13G
01/06/2025
6:40 AM
CytoMed Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/06/2025
6:40 AM
CytoMed Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/05/2024
4:00 PM
CytoMed Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/20/2024
6:00 AM
CytoMed Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
11:13 AM
CytoMed Therapeutics (Subject)
mDR Ltd (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/07/2024
6:44 AM
CytoMed Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/03/2024
6:00 AM
CytoMed Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2024
6:00 AM
CytoMed Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2024
12:43 PM
CytoMed Therapeutics (Filer)
Form 6-K/A
06/20/2024
12:50 PM
CytoMed Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2024
10:12 AM
CytoMed Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2024
5:10 AM
Choo Chee Kong (Filed by)
CytoMed Therapeutics (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:GDTC) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners